Frontiers in Oncology | Gynecological Oncology

Original Research

Published on 08 Feb 2024

Malignant mixed mullerian tumors: a SEER database review of rurality and treatment modalities on disease outcome

in Gynecological Oncology

Neusha Zadeh
Arjun Bhatt
Vaishnavi Sripiparu
Melisa Pasli
George Edwards
Michael C. Larkins
M. Sean Peach

Frontiers in Oncology

doi 10.3389/fonc.2024.1296496

2,939 views

Original Research

Published on 07 Feb 2024

Predicting the recurrence of usual-type cervical adenocarcinoma using a nomogram based on clinical and pathological factors: a retrospective observational study

in Gynecological Oncology

Yuting Liu
Ningning Zhang
Qing Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1320265

1,710 views
2 citations

Review

Published on 07 Feb 2024

New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment

in Gynecological Oncology

Biqing Chen
Liping Zhao
Rulin Yang
Tianmin Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1329133

4,486 views
3 citations

Original Research

Published on 06 Feb 2024

Predicting the status of lymphovascular space invasion using quantitative parameters from synthetic MRI in cervical squamous cell carcinoma without lymphatic metastasis

in Gynecological Oncology

Limei Guo
Runmei Zhang
Yi Xu
Wenqi Wu
Qian Zheng
Jianting Li
Jun Wang
Jinliang Niu

Frontiers in Oncology

doi 10.3389/fonc.2024.1304793

1,192 views

Case Report

Published on 02 Feb 2024

High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report

in Gynecological Oncology

Paola Giancontieri
Camilla Turetta
Giacomo Barchiesi
Angelina Pernazza
Gemma Pignataro
Giuliano D’Onghia
Daniele Santini
Federica Tomao

Frontiers in Oncology

doi 10.3389/fonc.2023.1307573

2,848 views
1 citation

Original Research

Published on 02 Feb 2024

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China

in Gynecological Oncology

Jinghong Chen
Mengpei Zhang
Kemin Li
Yuanqiong Duan
Jing Zeng
Qingli Li
Danqing Wang
Liang Song
Qintong Li
Rutie Yin

Frontiers in Oncology

doi 10.3389/fonc.2024.1336616

2,964 views
2 citations

Original Research

Published on 02 Feb 2024

Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy

in Gynecological Oncology

Giuseppe Marino
Tommaso Grassi
Elena De Ponti
Serena Negri
Filippo Testa
Daniela Giuliani
Martina Delle Marchette
Cristina Dell’Oro
Diletta Fumagalli
Gianluca Donatiello

Frontiers in Oncology

doi 10.3389/fonc.2024.1330481

2,446 views
1 citation

Case Report

Published on 02 Feb 2024

Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer

in Gynecological Oncology

Jennifer Wolf
Nicole Goncalves
Ioannis Alagkiozidis

Frontiers in Oncology

doi 10.3389/fonc.2024.1302724

1,237 views

Original Research

Published on 01 Feb 2024

Assessing the learning curve for transumbilical single-site laparoscopy for endometrial cancer

in Gynecological Oncology

Fanlin Li
Ying Zheng
Fan Yang
Jianhong Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1337719

1,268 views
1 citation

Case Report

Published on 31 Jan 2024

Case report: Malignant transformation of ovarian endometrioma during long term use of dienogest in a young lady

in Gynecological Oncology

Yi-Ting Chang
Ting-Fang Lu
Lou Sun
Yu-Hsiang Shih
Shih-Tien Hsu
Chin-Ku Liu
Sheau-Feng Hwang
Chien-Hsing Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1338472

2,861 views
1 citation

Review

Published on 30 Jan 2024

Ovarian steroid cell tumors: what do we know so far?

in Gynecological Oncology

Christina H. Wei
Oluwole Fadare

Frontiers in Oncology

doi 10.3389/fonc.2024.1331903

4,603 views
1 citation

Review

Published on 29 Jan 2024

Primary vaginal cancer after hysterectomy for benign conditions: a systematic review of the literature

in Gynecological Oncology

Jing Qian
Kaoma Gracious
Li Chen
Song Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1334778

4,409 views

Review

Published on 29 Jan 2024

Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert review for clinical practice

in Gynecological Oncology

Ignacio Romero
Eva Guerra
Ainhoa Madariaga
Luis Manso

Frontiers in Oncology

doi 10.3389/fonc.2023.1304303

3,171 views

Original Research

Published on 26 Jan 2024

E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells

in Gynecological Oncology

Andres Valdivia
Matthew Cowan
Horacio Cardenas
Ana Maria Isac
Guangyuan Zhao
Hao Huang
Daniela Matei

Frontiers in Oncology

doi 10.3389/fonc.2024.1304691

1,725 views
2 citations

Case Report

Published on 26 Jan 2024

Trastuzumab deruxtecan effectively controlled recurrent ovarian large-cell neuroendocrine carcinoma with low-level HER-2 expression: a case report

in Gynecological Oncology

Yurou Xing
Yidan Cao
Xin Wu
Yue Chen
Yongsheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1339806

1,916 views
3 citations

Original Research

Published on 26 Jan 2024

Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell carcinoma of the cervix

in Gynecological Oncology

Zhao Xing
Shen Danhua
Zhang Xiaobo

Frontiers in Oncology

doi 10.3389/fonc.2024.1354838

1,530 views
1 citation

Navigation group

Articles

Malignant mixed mullerian tumors: a SEER database review of rurality and treatment modalities on disease outcome

Predicting the recurrence of usual-type cervical adenocarcinoma using a nomogram based on clinical and pathological factors: a retrospective observational study

New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment

Predicting the status of lymphovascular space invasion using quantitative parameters from synthetic MRI in cervical squamous cell carcinoma without lymphatic metastasis

High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report

PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China

Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy

Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer

Assessing the learning curve for transumbilical single-site laparoscopy for endometrial cancer

Case report: Malignant transformation of ovarian endometrioma during long term use of dienogest in a young lady

Ovarian steroid cell tumors: what do we know so far?

Primary vaginal cancer after hysterectomy for benign conditions: a systematic review of the literature

Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert review for clinical practice

E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells

Trastuzumab deruxtecan effectively controlled recurrent ovarian large-cell neuroendocrine carcinoma with low-level HER-2 expression: a case report

Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell carcinoma of the cervix